loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$15.66
Offen:
$15.54
24-Stunden-Volumen:
109.00K
Relative Volume:
6.49
Marktkapitalisierung:
$747.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$15.26
$16.09
1-Wochen-Bereich:
Value
$14.31
$16.20
52-Wochen-Spanne:
Value
$14.31
$16.20

Agomab Therapeutics Nv Adr Stock (AGMB) Company Profile

Name
Firmenname
Agomab Therapeutics Nv Adr
Name
Sektor
Healthcare (1111)
Name
Branche
Biotechnology (622)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AGMB's Discussions on Twitter

Compare AGMB vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AGMB
Agomab Therapeutics Nv Adr
 15.34 763.22M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 491.47 117.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 803.17 82.85B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
 821.96 51.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 314.40 40.75B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 346.07 38.33B 4.98B 69.60M 525.67M 0.5198

Agomab Therapeutics Nv Adr Aktie (AGMB) Neueste Nachrichten

pulisher
Feb 09, 2026

Agomab Announces Closing of Initial Public Offering - Benzinga

Feb 09, 2026
pulisher
Feb 08, 2026

EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO - Mint

Feb 08, 2026
pulisher
Feb 06, 2026

Agomab Therapeutics opens below IPO price in Nasdaq debut By Investing.com - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 05, 2026

Agomab prices IPO at $16 per share, aims to raise $200 million - Investing.com Australia

Feb 05, 2026
pulisher
Feb 05, 2026

Agomab prices IPO at $16 per share, aims to raise $200 million By Investing.com - Investing.com India

Feb 05, 2026

Finanzdaten der Agomab Therapeutics Nv Adr-Aktie (AGMB)

Es liegen keine Finanzdaten für Agomab Therapeutics Nv Adr (AGMB) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie AGMB

biotechnology ROIV
$26.45
price down icon 1.12%
biotechnology RPRX
$45.19
price up icon 0.87%
biotechnology INCY
$101.10
price up icon 0.35%
biotechnology BNTX
$105.87
price up icon 0.10%
biotechnology INSM
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):